Document is current
Any future updates will be listed below
-
Authors
Gonzalez, Estela https://orcid.org/0000-0002-4296-0080
Anderson, Michelle A. E. https://orcid.org/0000-0003-1510-2942
Ang, Joshua X. D. https://orcid.org/0000-0002-4710-8831
Nevard, Katherine https://orcid.org/0000-0002-1008-6587
Shackleford, Lewis https://orcid.org/0000-0002-8154-5154
Larrosa-Godall, Mireia https://orcid.org/0000-0003-1748-7815
Leftwich, Philip T. https://orcid.org/0000-0001-9500-6592
Alphey, Luke https://orcid.org/0000-0002-2916-3802
-
Funding
Funding for this research was provided by:
Bill & Melinda Gates Foundation (INV-008549)
Biotechnology and Biological Sciences Research Council (BBS/E/I/00007033, BBS/E/I/00007038, and BBS/E/I/00007039)
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 14 April 2025
First Online: 18 April 2025
Competing interests
: LA is an adviser to Synvect Inc and Biocentis Ltd, with equity and/or financial interest in those companies. All remaining authors declare that they have no competing interests.
